Global CGT CDMO Competitive Landscape Professional Research Report 2024

Research Summary

A CGT CDMO (Contract Development and Manufacturing Organization for Cell and Gene Therapy) is a specialized service provider that supports the biopharmaceutical industry by offering comprehensive development and manufacturing solutions for cell and gene therapies. These organizations facilitate every stage of the therapy development process, from research and development to clinical trial material production, regulatory compliance, and large-scale commercial manufacturing. By leveraging advanced facilities, expert personnel, and regulatory expertise, CGT CDMOs enable biotech and pharmaceutical companies to accelerate the development and commercialization of innovative treatments. This allows companies to focus on their core competencies while ensuring efficient, high-quality production and adherence to regulatory standards, ultimately speeding up the delivery of advanced therapies to patients.

According to DIResearch's in-depth investigation and research, the global CGT CDMO market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of CGT CDMO include WuXi AppTec, OBiO, GenScript, Porton, Lonza, Pharmaron, Catalent, Thermo Fisher, Oxford Biomedica (OXB), Asymchem, Rentschler Biopharma, Novartis etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of CGT CDMO. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global CGT CDMO market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the CGT CDMO market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of CGT CDMO industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of CGT CDMO Include:

WuXi AppTec

OBiO

GenScript

Porton

Lonza

Pharmaron

Catalent

Thermo Fisher

Oxford Biomedica (OXB)

Asymchem

Rentschler Biopharma

Novartis

CGT CDMO Product Segment Include:

Immune Cells

Stem Cells

Viral Vectors

Plasmid DNA

CGT CDMO Product Application Include:

Pharmaceutical and Biotechnology Companies

Research and Academic Institutions

Hospital

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global CGT CDMO Industry PESTEL Analysis

Chapter 3: Global CGT CDMO Industry Porter's Five Forces Analysis

Chapter 4: Global CGT CDMO Major Regional Market Size and Forecast Analysis

Chapter 5: Global CGT CDMO Market Size and Forecast by Type and Application Analysis

Chapter 6: North America CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa CGT CDMO Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global CGT CDMO Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 CGT CDMO Market Overview

1.1 Product Definition and Statistical Scope

1.2 CGT CDMO Product by Type

1.2.1 Global CGT CDMO Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Immune Cells

1.2.3 Stem Cells

1.2.4 Viral Vectors

1.2.5 Plasmid DNA

1.3 CGT CDMO Product by Application

1.3.1 Global CGT CDMO Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Pharmaceutical and Biotechnology Companies

1.3.3 Research and Academic Institutions

1.3.4 Hospital

1.3.5 Others

1.4 Global CGT CDMO Market Revenue Analysis (2019-2030)

1.5 CGT CDMO Market Development Status and Trends

1.5.1 CGT CDMO Industry Development Status Analysis

1.5.2 CGT CDMO Industry Development Trends Analysis

2 CGT CDMO Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 CGT CDMO Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global CGT CDMO Market Analysis by Regions

4.1 CGT CDMO Overall Market: 2023 VS 2024 VS 2030

4.2 Global CGT CDMO Revenue and Forecast Analysis (2019-2030)

4.2.1 Global CGT CDMO Revenue and Market Share by Region (2019-2024)

4.2.2 Global CGT CDMO Revenue Forecast by Region (2025-2030)

5 Global CGT CDMO Market Size by Type and Application

5.1 Global CGT CDMO Market Size by Type

5.2 Global CGT CDMO Market Size by Application

6 North America

6.1 North America CGT CDMO Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America CGT CDMO Market Size by Type

6.4 North America CGT CDMO Market Size by Application

6.5 North America CGT CDMO Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe CGT CDMO Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe CGT CDMO Market Size by Type

7.4 Europe CGT CDMO Market Size by Application

7.5 Europe CGT CDMO Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China CGT CDMO Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China CGT CDMO Market Size by Type

8.4 China CGT CDMO Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) CGT CDMO Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) CGT CDMO Market Size by Type

9.4 APAC (excl. China) CGT CDMO Market Size by Application

9.5 APAC (excl. China) CGT CDMO Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America CGT CDMO Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America CGT CDMO Market Size by Type

10.4 Latin America CGT CDMO Market Size by Application

10.5 Latin America CGT CDMO Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa CGT CDMO Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa CGT CDMO Market Size by Type

11.4 Middle East & Africa CGT CDMO Market Size by Application

11.5 Middle East & Africa CGT CDMO Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global CGT CDMO Market Revenue by Key Manufacturers (2020-2024)

12.2 CGT CDMO Competitive Landscape Analysis and Market Dynamic

12.2.1 CGT CDMO Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 WuXi AppTec

13.1.1 WuXi AppTec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 WuXi AppTec CGT CDMO Product Portfolio

13.1.3 WuXi AppTec CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 OBiO

13.2.1 OBiO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 OBiO CGT CDMO Product Portfolio

13.2.3 OBiO CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 GenScript

13.3.1 GenScript Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 GenScript CGT CDMO Product Portfolio

13.3.3 GenScript CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Porton

13.4.1 Porton Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Porton CGT CDMO Product Portfolio

13.4.3 Porton CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Lonza

13.5.1 Lonza Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Lonza CGT CDMO Product Portfolio

13.5.3 Lonza CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Pharmaron

13.6.1 Pharmaron Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Pharmaron CGT CDMO Product Portfolio

13.6.3 Pharmaron CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Catalent

13.7.1 Catalent Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Catalent CGT CDMO Product Portfolio

13.7.3 Catalent CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Thermo Fisher

13.8.1 Thermo Fisher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Thermo Fisher CGT CDMO Product Portfolio

13.8.3 Thermo Fisher CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Oxford Biomedica (OXB)

13.9.1 Oxford Biomedica (OXB) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Oxford Biomedica (OXB) CGT CDMO Product Portfolio

13.9.3 Oxford Biomedica (OXB) CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Asymchem

13.10.1 Asymchem Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Asymchem CGT CDMO Product Portfolio

13.10.3 Asymchem CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Rentschler Biopharma

13.11.1 Rentschler Biopharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Rentschler Biopharma CGT CDMO Product Portfolio

13.11.3 Rentschler Biopharma CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Novartis

13.12.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Novartis CGT CDMO Product Portfolio

13.12.3 Novartis CGT CDMO Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 CGT CDMO Industry Chain Analysis

14.2 CGT CDMO Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 CGT CDMO Typical Downstream Customers

14.4 CGT CDMO Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support